Research and Markets: Global Acquired Gene or Chromosome Alterations Pipeline Review 2015

Research and Markets (http://www.researchandmarkets.com/research/lrzjwd/acquired_gene_or) has announced the addition of the "Acquired Gene or Chromosome Alterations - Pipeline Review, 2015" report to their offering.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key genetic tests for Acquired Gene or Chromosome Alterations pipeline products.

Scope

• Extensive coverage of the genetic tests for Acquired Gene or Chromosome Alterations under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of genetic tests for Acquired Gene or Chromosome Alterations and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Key Topics Covered:

1 Tables & Figures

2 Introduction

3 Products under Development

4 Acquired Gene or Chromosome Alterations - Pipeline Products under Development by Companies

5 Acquired Gene or Chromosome Alterations Companies and Product Overview

6 Acquired Gene or Chromosome Alterations- Recent Developments

7 Appendix

Companies Mentioned

• Abbott Diagnostics
• Agendia NV
• AltheaDx, Inc.
• Amarantus Bioscience Holdings, Inc.
• AstraZeneca Plc
• AutoGenomics, Inc.
• Biocept, Inc.
• Cepheid
• Chinese University of Hong Kong
• Columbia University
• Dana-Farber Cancer Institute, Inc.
• DiaCarta
• Exosome Diagnostics, Inc.
• Gencurix Co., Ltd.
• GeneFirst Ltd
• GenMark Diagnostics, Inc.
• Genomic Health, Inc.
• Genomic Vision
• GenomicTree, Inc.
• German Cancer Research Center
• H. Lee Moffitt Cancer Center & Research Institute, Inc.
• Harvard University
• Helmholtz Centre for Infection Research
• Illumina, Inc.
• Insight Genetics, Inc.
• InVivoScribe Technologies, Inc.
• Med BioGene Inc.
• Merrimack Pharmaceuticals, Inc.
• MolecularMD, Corp.
• Multiplicom N.V.
• Myriad Genetics, Inc.
• Panagene Inc.
• Pangaea Biotech, S.L.
• PDI, lnc.
• PharmaSeq, Inc.
  

For more information visit http://www.researchandmarkets.com/research/lrzjwd/acquired_gene_or

View source version on businesswire.com: http://www.businesswire.com/news/home/20151127005286/en/